Trials / Completed
CompletedNCT01703793
Safety and Efficacy Study in Subjects With Seborrheic Dermatitis
A Parallel-group, Vehicle-controlled, Randomized, Double-blind Study of the Efficacy and Safety of Product 49778 and Product 10156 in Subjects With Seborrheic Dermatitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Medicis Global Service Corporation · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if two test products are safe and effective in the treatment of seborrheic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Test Product 49778 | |
| DRUG | Test Product 10156 | |
| DRUG | Vehicle (placebo) |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2012-10-11
- Last updated
- 2013-01-09
Locations
22 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01703793. Inclusion in this directory is not an endorsement.